Akers Biosciences Inc (NASDAQ:AKER):
Akers Biosciences Inc (NASDAQ:AKER) ended its previous trading session at $0.91 with the Gain of 0.16%. The company’s market cap is $11.52 Million, and the average volume is $384.08 Million. The 52-Week High range of the stock is $7.84, while the 52-week low range is $0.57. The Price to Sales (P/S) of the stock is 5.01, while P/B (Price to Book) stands at 1.38. When we look at the Volatility of the company, Week Volatility is at 6.76% whereas Month Volatility is at 8.76%.
According to 1.56 analysts, the Average Revenue Estimate for the current Fiscal quarter is $990000 and the Low Revenue estimate is $36.54 Million, while the High Revenue estimate is $570000.
Akers Biosciences Inc (NASDAQ:AKER) analysts on average have given a price target of $4 on AKER stock.
According to the Recommendation Trends of the stock polled by Zacks Investment Research for this month, the company has a consensus recommendation of 2 out of the scale from 1 to 5 where 1 stands for Strong Buy and 5 means Strong Sell.
AMN Healthcare Services Inc (NYSE:AMN):
AMN Healthcare Services Inc (NYSE:AMN) shares declined -1.66% and ended the day at $49.18. Its 52-week high and low range is between $68.2 and $47.05. The company’s outstanding shares are 47.38 Million. The volume of the company in the last trading session was 641670. The stock has a market cap of 2.33 Billion. The Stock shows P/E value of 16.89 and Forward P/E of 14.02.
According to Finviz reported data, The SMA20 of the stock is at -16.48%, SMA50 is -16.34 percent, while SMA200 is -14.43%. The stock is currently has its Return on Assets (ROA) value of 9.9 Percent. The Return on Investment and Return on Equity (ROE) values are 14.6 percent and 23 percent, respectively.
The company’s ATR (Average True Range) is 1.97. The Weekly Volatility is 2.82% and the Monthly Volatility is 3.27%.
When we look at the Analyst Recommendations of the stock, the company has 1.9 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell.
AMN Healthcare Services Inc (NYSE:AMN) analysts on average have given a price target of $4 on AMN stock.
AMN Healthcare Services Inc’s Average Earnings Estimate for the current quarter is $0.7, according to consensus of 9 analysts. The low EPS estimate is $0.66, while the high EPS estimate is $0.76.
Average Revenue Estimate of the company for the current Fiscal Quarter is $525.39 Million, according to consensus of 9 analysts. The higher end of the revenue estimate is $527.6 Million and the lower end is $523.4 Million.